71 related articles for article (PubMed ID: 6228463)
1. Hepatitis B vaccine: safety study in anti-HBs seronegative human volunteers.
Kaufmann R; Mondorf AW; Uthemann H; Bauer H; Prince AM
Dev Biol Stand; 1983; 54():229-35. PubMed ID: 6228463
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccine: safety study in anti-HBs seropositive human volunteers.
Kaufmann R; Mondorf AW; Uthemann H; Bauer H; Prince AM
Dev Biol Stand; 1983; 54():223-7. PubMed ID: 6228462
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B vaccine: clinical trials in high-risk settings in France. (September 1975-September 1982).
Goudeau A; Dubois F; Barin F; Dubois MC; Coursaget P
Dev Biol Stand; 1983; 54():267-84. PubMed ID: 6228468
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of heat-inactivated hepatitis B vaccine (CLB) in low risk human volunteers and in patients treated with chronic haemodialysis in the Netherlands.
Reerink-Brongers EE; Lelie PN; Reesink HW; Dees PJ; Brummelhuis HG; van Aken WG
Dev Biol Stand; 1983; 54():197-203. PubMed ID: 6228459
[TBL] [Abstract][Full Text] [Related]
5. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
[TBL] [Abstract][Full Text] [Related]
6. Efficacy trial of heat-inactivated hepatitis B vaccine (CLB) in male homosexuals in the Netherlands.
Coutinho RA; Lelie PN; Albrecht-van Lent P; Stoutjesdijk L; Huisman J; Kuipers H; Schut LJ; Reerink-Brongers EE; Reesink HW; van Aken WG
Dev Biol Stand; 1983; 54():287-92. PubMed ID: 6228469
[TBL] [Abstract][Full Text] [Related]
7. Active hepatitis B immunization with an experimental German vaccine. I. Immunogenicity studies in healthy adults. II. The primary 19 S and 7 S responses to HBsAg in healthy adults. III. Immunogenicity studies in hemodialysis patients.
Scheiermann N; Kuwert EK
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):439-55. PubMed ID: 6485639
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees.
Purcell RH; Gerin JL
Am J Med Sci; 1975; 270(2):395-9. PubMed ID: 828832
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B in haemodialysis: vaccination against HBS antigen.
Crosnier J
Proc Eur Dial Transplant Assoc; 1981; 18():231-40. PubMed ID: 7036150
[TBL] [Abstract][Full Text] [Related]
11. Kinetics, subtype specificity and immunoglobulin class of anti-HBs induced by hepatitis B vaccine.
Legler K; Strohmeyer H; Ritter S; Gerlich WH; Thomssen R
Dev Biol Stand; 1983; 54():179-89. PubMed ID: 6228457
[TBL] [Abstract][Full Text] [Related]
12. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
13. Safety and potency aspects in the preparation of an experimental HBsAg vaccine.
Thomssen R; Gerlich WH; Böttcher U; Legler K; Ritter S; Stibbe W; Weinmann W; Klinge O; Pfeifer U
Dev Biol Stand; 1983; 54():23-31. PubMed ID: 6228464
[TBL] [Abstract][Full Text] [Related]
14. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen.
Huang LM; Chiang BL; Lee CY; Lee PI; Chi WK; Chang MH
Hepatology; 1999 Mar; 29(3):954-9. PubMed ID: 10051503
[TBL] [Abstract][Full Text] [Related]
15. [Persistence of HB vaccine immune protection and response to hepatitis B booster immunization].
Li H; Li R; Liao S; Yang J; Zeng X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):54-9. PubMed ID: 11367735
[TBL] [Abstract][Full Text] [Related]
16. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
[TBL] [Abstract][Full Text] [Related]
18. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of HBeAg in the New York Blood Center hepatitis B vaccine.
Vnek J; Hashimoto N; Prince AM
Dev Biol Stand; 1983; 54():217-21. PubMed ID: 6228461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]